CRUK–AACR Joint Conference on Engineering and Physical Sciences in Oncology 2019: Programme

CRUK-AACR Joint Conference on Physical Sciences in Oncology 2019

The conference programme will explore new ways to transform our understanding of biology and to better detect and treat cancer, enabling expert speakers to address some of the toughest challenges in cancer research from a variety of perspectives. 


09:30 – 10:40

Registration, networking and poster set-up

10:40 – 11:00

Welcome from Cancer Research UK and AACR

Ian Foulkes, Cancer Research UK

Elizabeth M. Jaffee, The Dana and Albert “Cubby” Broccoli Professor of Oncology and The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, US

11:00 – 12:00

Integrative Approaches to Reconstruct the Tumour Microenvironment

Sylvia Plevritis, Stanford, US

12:00 – 13:30

Networking lunch, exhibition and poster session A

13:30 ​– 15:30

What are the barriers to progress in cancer?

This session will outline some of the largest barriers to cancer treatment, both scientifically and clinically, and those that are arising as new treatments evolve.

Chair and speaker: Charlie Swanton, Francis Crick Institute and UCL Cancer Institute, UK

Speakers: René Bernards, Netherlands Cancer Institute, Netherlands 

Elizabeth M. Jaffee, The Dana and Albert “Cubby” Broccoli Professor of Oncology and The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, US

15:30 – 16.00

Networking, exhibition and refreshment break

16:00 – 18:00

Detect: Monitoring disease state

This session will focus on new technologies to monitor all aspects of disease state, from therapy response to resistance detection in both clinical and preclinical settings.

Chair and speaker: Kevin Brindle, Cancer Research UK Cambridge Institute, UK

Speakers: Peter Choyke, National Cancer Institute, US

Oliver Jonas, Brigham and Women's Hospital, Harvard Medical School, US

Wolfgang Weber, Technical University of Munich, Germany

18:00 – 19:30

Networking drinks and poster session B




07:30 – 08:10

Arrival, refreshments and poster set-up

08:10 – 08:20

Opening remarks

Matt Kaiser, Cancer Research UK

08:20 – 09:30

Promoting multi-disciplinary collaboration across networks

This session will focus on the challenges and approaches to building cancer-centric multidisciplinary ecosystems, both in America and the UK.

Chair: Matt Kaiser, Cancer Research UK

Speakers: Don Ingber, Wyss Institute for Biologically Inspired Engineering, US

Paul Workman, The Institute of Cancer Research, UK

09:30 – 10:00

Networking, exhibition and refreshment break

10:00 – 12:00

Understand: Cancer biophysics and clinical challenges

This session will focus on advances in biophysics and their application to the study of clinical challenges including treatment failure and metastasis.

Chair and speaker: Owen Sansom, Cancer Research UK Beatson Institute, UK

Speakers: Buzz Baum, University College London, UK

Simon Walker-Samuel, University College London, UK 

12:00 – 13:00

Networking lunch and poster session C

13:00 – 15:00

Understand: Cancer research in the big data era

This session will highlight how big data and artificial intelligence can accelerate cancer research.

Chair and speaker: Nils Gehlenborg, Harvard, US 

Speakers: Bissan Al-Lazikani, The Institute of Cancer Research, UK

Mihaela van der Schaar, University of Cambridge and The Alan Turing Institute, UK

15:00 – 15:30

Networking, exhibition and refreshment break 

15:30 – 18:00

Detect: Emerging technologies for cancer diagnosis

This session will focus on state-of-the-art cancer detection technology and its potential to improve clinical diagnosis.

Chair and speaker: Molly Stevens, Imperial College London, UK

Speakers: Sarah Bohndiek, Cancer Research UK Cambridge Institute, UK

Jason Lewis, Memorial Sloan Kettering Cancer Center, US

Vasilis Ntziachristos, Technical University Munich, Germany and Helmholtz Zentrum Munich, Germany

Peter van Zijl, Johns Hopkins University School of Medicine, US   


Conference close 

18:15 – 19.30 

Networking drinks and poster session D 

19:30 – late

Conference dinner

Leonardo Royal Hotel London Tower Bridge  


08:45 – 09:00

Arrival and refreshments

09:00 – 09:10

Opening remarks 

Kevin Brindle, Cancer Research UK Cambridge Institute, UK

09:10 – 10:10

Tracing the basis of epithelial cell competition in normal and perturbed states

Chair: Kevin Brindle, University of Cambridge, UK

Ben Simons, Cancer Reserach UK Cambridge Institute, UK 

10:10 – 10:40

Networking and refreshment break

10:40 – 12:40

Treat: Engineered solutions to enhance therapy

This session will discuss emerging technologies (radiotherapeutic, surgical, digital) and devices that can help in the fight against cancer.

Chair and speaker: Uwe Oelfke, Institute of Cancer Research, UK

Bernd Pichler, University Hospital Tübingen, Germany

Paula Hammond, Massachusetts Institute of Technology, US

Shana Kelley, University of Toronto, Canada

12:40 – 13:40

Networking lunch and poster session E

13:40 – 15:40

Treat: Novel therapeutic approaches

This session will discuss emerging therapeutics and therapeutic technologies that can help in the fight against cancer.

Chair and speaker: Sangeeta Bhatia, Massachusetts Institute of Technology, US

Speakers: Angela Koehler, Massachusetts Institute of Technology, US

Edward Tate, Imperial College London and The Francis Crick Institute, UK 

Terry Rabbitts, University of Oxford, UK

15:40 – 15:45

Panel change 

15:45 – 16:30

Future leaders session

Chair: Sangeeta Bhatia, Massachusetts Institute of Technology, US

16:30 – 16:45

Closing remarks and poster prizes 


Continuing Medical Education (CME)

Accreditation Statement
The American Association for Cancer Research (AACR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.
Credit Designation Statement
AACR has designated this live activity for a maximum of 17.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Credit certification for individual sessions may vary, dependent upon compliance with the ACCME Accreditation Criteria. The final number of credits may vary from the maximum number indicated above.
Claiming (CME) Credit
Physicians and other health care professionals seeking AMA PRA Category 1 Credit(s)TM for this live continuing medical education activity must complete the online CME Request for Credit Survey by November 27, 2019. Certificates will only be issued to those who complete the survey. The Request for Credit Survey is available below and via email. Your CME certificate will be sent to you via email after the completion of the activity.
Statement of Educational Need, Target Audience, and Learning Objectives
Since the founding of the U.S. National Cancer Institute’s founding of the Physical Sciences – Oncology Centers program in 2009, there has been a growing interest in the U.S. and abroad to explore innovative approaches and attract non-traditional scientific disciplines to the cancer research community.  According to the IARC’s Section of Cancer Surveillance, in 2018, the number of new cancer cases is estimated to exceed 18,000,000 and the number of cancer deaths will exceed 9,500,000.  Bringing medical oncologists, cancer biologists, mathematicians, chemists, engineers, data scientists, etc. are necessary to take advantage of technological advances and opportunities to address the cancer burden from converging areas.
Sessions will address scientific and clinical barriers to treatment success, preclinical and clinical detection of response and resistance, and artificial intelligence, big data, and emerging technologies (surgical, pathological, radiologic) applications for improving early detection and improved patient care.
After participating in this CME activity, physicians should be able to:
1.            Identify advances in technologies that have application to monitoring both response and resistance to therapeutic interventions.
2.            Assess the potential impact of new radiologic, surgical, and digital technologies and their impact in cancer detection and treatment.
3.            Explain the clinical challenges that may be addressed by the integration of big data, machine learning, and artificial intelligence.
4.            Articulate how advances in the understanding of biophysics in relation to cancer may impact metastasis research and treatment failure.
Disclosure Statement
It is the policy of the AACR that the information presented at AACR CME activities will be unbiased and based on scientific evidence. To help participants make judgments about the presence of bias, AACR will provide information that Scientific Program Committee members and speakers have disclosed about financial relationships they have with commercial entities that produce or market products or services related to the content of this CME activity. This disclosure information will be made available in the Program/Proceedings of this conference.
Acknowledgment of Financial or Other Support
This activity is supported by Professional Educational Grants and will be disclosed at the activity.
Questions about CME?
Please contact the Office of CME at (215) 440-9300 or